| Nome |
# |
|
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity, file e309ade4-cfe7-3969-e053-3a05fe0a2c94
|
147
|
|
Pharmacology, physiology and genetics of the neuropeptide s system, file e309ade4-e90d-3969-e053-3a05fe0a2c94
|
98
|
|
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test, file e309ade4-d513-3969-e053-3a05fe0a2c94
|
95
|
|
Neuropeptide S receptor ligands: a patent review (2005-2016), file e309ade3-a082-3969-e053-3a05fe0a2c94
|
66
|
|
Novel Mixed NOP/Opioid Receptor Peptide Agonists, file e309ade4-c82b-3969-e053-3a05fe0a2c94
|
62
|
|
The concise guide to pharmacology 2019/20: G protein-coupled receptors, file e309ade2-c531-3969-e053-3a05fe0a2c94
|
61
|
|
The concise guide to pharmacology 2021/22: G protein-coupled receptors, file e309ade5-35a0-3969-e053-3a05fe0a2c94
|
52
|
|
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors, file e309ade3-b3df-3969-e053-3a05fe0a2c94
|
51
|
|
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies, file e309ade2-1260-3969-e053-3a05fe0a2c94
|
44
|
|
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2, file e309ade2-f967-3969-e053-3a05fe0a2c94
|
38
|
|
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade3-ecc7-3969-e053-3a05fe0a2c94
|
35
|
|
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands, file e309ade3-b6ac-3969-e053-3a05fe0a2c94
|
33
|
|
Pharmacological and neurobiological
studies on Neuropeptide S
and its receptor, file e309ade1-d71f-3969-e053-3a05fe0a2c94
|
26
|
|
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice, file e309ade2-d8bb-3969-e053-3a05fe0a2c94
|
11
|
|
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands, file 43c608e3-3b7b-45a9-9ae2-141bed32b171
|
10
|
|
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040, file e309ade2-ab4e-3969-e053-3a05fe0a2c94
|
9
|
|
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics, file e309ade4-45a7-3969-e053-3a05fe0a2c94
|
9
|
|
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68., file e309ade2-090f-3969-e053-3a05fe0a2c94
|
5
|
|
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists, file e309ade5-2bc4-3969-e053-3a05fe0a2c94
|
5
|
|
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies, file e309ade0-3784-3969-e053-3a05fe0a2c94
|
4
|
|
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze., file e309ade0-4aaf-3969-e053-3a05fe0a2c94
|
4
|
|
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors, file e309ade2-4f09-3969-e053-3a05fe0a2c94
|
4
|
|
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1, file e309ade0-4314-3969-e053-3a05fe0a2c94
|
3
|
|
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation, file c3bdd94d-1aa7-47a5-8aca-7490d216de56
|
2
|
|
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS., file e309ade0-289d-3969-e053-3a05fe0a2c94
|
2
|
|
Pharmacological characterization of tachykinin tetrabranched derivatives, file e309ade0-3fd1-3969-e053-3a05fe0a2c94
|
2
|
|
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands, file e309ade0-b93f-3969-e053-3a05fe0a2c94
|
2
|
|
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations, file e309ade1-09f6-3969-e053-3a05fe0a2c94
|
2
|
|
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade1-97a2-3969-e053-3a05fe0a2c94
|
2
|
|
Neuropeptide S receptor ligands: a patent review (2005-2016), file e309ade1-ad8b-3969-e053-3a05fe0a2c94
|
2
|
|
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test, file e309ade2-4743-3969-e053-3a05fe0a2c94
|
2
|
|
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress, file e309ade2-a1db-3969-e053-3a05fe0a2c94
|
2
|
|
Pharmacological characterization of naloxegol: In vitro and in vivo studies, file e309ade5-35a2-3969-e053-3a05fe0a2c94
|
2
|
|
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus, file 1d278498-4609-494e-a67b-35b21cb260b1
|
1
|
|
Preclinical effects of cannabidiol in an experimental model of migraine, file 2ad66dee-3808-497c-9e3f-7f5e4b760ea7
|
1
|
|
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay, file ac614fbb-c87a-42ea-aaa0-7286f21e9c3e
|
1
|
|
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors, file d3b05279-a93f-4c95-a0d4-b9ec2faa132e
|
1
|
|
Synthesis and biological activity of human neuropeptide S analogues modified in position 2, file e309ade0-2575-3969-e053-3a05fe0a2c94
|
1
|
|
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice, file e309ade0-264e-3969-e053-3a05fe0a2c94
|
1
|
|
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists., file e309ade0-2819-3969-e053-3a05fe0a2c94
|
1
|
|
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists., file e309ade0-2a4c-3969-e053-3a05fe0a2c94
|
1
|
|
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68)., file e309ade0-33a0-3969-e053-3a05fe0a2c94
|
1
|
|
null, file e309ade0-3e2a-3969-e053-3a05fe0a2c94
|
1
|
|
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives, file e309ade0-3fd2-3969-e053-3a05fe0a2c94
|
1
|
|
null, file e309ade0-4334-3969-e053-3a05fe0a2c94
|
1
|
|
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S
receptor: structure activity and pharmacological studies, file e309ade0-48f8-3969-e053-3a05fe0a2c94
|
1
|
|
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor, file e309ade0-8dfc-3969-e053-3a05fe0a2c94
|
1
|
|
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13), file e309ade1-06d1-3969-e053-3a05fe0a2c94
|
1
|
|
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test, file e309ade1-e9fc-3969-e053-3a05fe0a2c94
|
1
|
|
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence, file e309ade2-12d8-3969-e053-3a05fe0a2c94
|
1
|
|
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine, file e309ade2-1a68-3969-e053-3a05fe0a2c94
|
1
|
|
Modulation of the NOP receptor signaling affects resilience to acute stress, file e309ade2-5686-3969-e053-3a05fe0a2c94
|
1
|
|
NOP Ligands for the Treatment of Anxiety and Mood Disorders, file e309ade2-56db-3969-e053-3a05fe0a2c94
|
1
|
|
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors, file e309ade2-64a0-3969-e053-3a05fe0a2c94
|
1
|
|
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders, file e309ade2-b56a-3969-e053-3a05fe0a2c94
|
1
|
|
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress, file e309ade5-252f-3969-e053-3a05fe0a2c94
|
1
|
| Totale |
915 |